600572.SS
600572.SS
CNE000001H86
ZHEJIANG CONBA PHARMACEUTICAL C
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 (Est.) Change %
Total Revenue 6.473.433.792 0
--
Cost of Revenue 3.022.603.371 --
--
Gross Profit 3.450.830.421 --
--
2.826.645.427 --
--
Operating Income 624.184.994 --
--
Pretax Income 645.168.572 --
--
Net Income Common Stockholders 474.363.103 --
--
-- --
--
-- --
--
ende